Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
5.14
+0.18 (3.63%)
Jun 29, 2026, 11:29 AM EDT - Market open
Cingulate Market Cap
Cingulate has a market cap or net worth of $69.23 million as of June 29, 2026. Its market cap has increased by 270.59% in one year.
Market Cap
69.23M
Enterprise Value
48.34M
1-Year Change
270.59%
Ranking
Category
Stock Price
$5.14
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has increased from $64.29M to $69.23M, an increase of 7.69%. That is a compound annual growth rate of 1.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 69.23M | 136.08% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 72.83M |
| Acrivon Therapeutics | 71.91M |
| XBiotech | 71.04M |
| Pliant Therapeutics | 70.05M |
| BeyondSpring | 69.49M |
| Seres Therapeutics | 68.56M |
| eXoZymes | 68.09M |
| ImageneBio | 67.90M |